Trexquant Investment LP Novo Nordisk A S Transaction History
Trexquant Investment LP
- $7.59 Billion
- Q3 2024
A detailed history of Trexquant Investment LP transactions in Novo Nordisk A S stock. As of the latest transaction made, Trexquant Investment LP holds 169,979 shares of NVO stock, worth $14.1 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
169,979
Previous 6,028
2719.82%
Holding current value
$14.1 Million
Previous $860,000
2253.37%
% of portfolio
0.27%
Previous 0.01%
Shares
16 transactions
Others Institutions Holding NVO
# of Institutions
1,939Shares Held
318MCall Options Held
5.49MPut Options Held
7.78M-
Jennison Associates LLC20.2MShares$1.68 Billion1.5% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.19 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.19 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.11 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$1.01 Billion3.76% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $188B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...